<PAGE>

                                                                    EXHIBIT 32.2


                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly  Report of Advanced  Biotherapy,  Inc.
(the  "Company")  on Form 10-QSB for the quarter  ended June 30, 2003,  as filed
with the  Securities  and Exchange  Commission on the date hereof (the "Periodic
Report"),  I, William M.  Finkelstein,  Chief Financial  Officer of the Company,
certify,  pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

         3.       the Periodic  Report fully complies with the  requirements  of
                  Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
                  and

         4.       the  information  contained  in  the  Periodic  Report  fairly
                  presents,  in all material respects,  the financial  condition
                  and results of operations of the Company.



Dated: August 13, 2003              /s/ William M. Finkelstein
                                    ------------------------------------------
                                    Chief Financial Officer

